Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)

NCT01585311 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1540

Last updated 2019-09-10

No results posted yet for this study

Summary

The purpose of this retrospective study is to test the hypothesis that uncontrolled tachycardia serves as a risk factor for adverse cardiovascular events and poor outcome after Subarachnoid Hemorrhage (SAH).

Conditions

  • Subarachnoid Hemorrhage (SAH)
  • Tachycardia

Sponsors & Collaborators

Principal Investigators

  • Jan Claassen, MD · Columbia University

  • J. Michael Schmidt, PhD · Columbia University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01585311 on ClinicalTrials.gov